Inpixon - Common Stock (NQ:INPX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 12, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inpixon - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Why Is Inpixon (INPX) Stock Up 38% Today? ↗

September 28, 2023

Inpixon stock is rising higher on Thursday with heavy trading despite any news that acts as a catalyst for the INPX movement!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 28, 2023

We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories!

Via InvestorPlace

12 Information Technology Stocks Moving In Wednesday's After-Market Session ↗

September 27, 2023

Via Benzinga

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session ↗

September 27, 2023

Via Benzinga

Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 08, 2023

Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.

Via Benzinga

12 Information Technology Stocks Moving In Friday's Pre-Market Session ↗

September 08, 2023

Via Benzinga

Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

September 08, 2023

Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 08, 2023

Pre-market stock movers are a hot topic worth checking out on Friday with a look at the biggest winners and losers today!

Via InvestorPlace

12 Information Technology Stocks Moving In Tuesday's After-Market Session ↗

September 05, 2023

Via Benzinga

10 Information Technology Stocks Moving In Tuesday's Pre-Market Session ↗

August 22, 2023

Via Benzinga

12 Information Technology Stocks Moving In Thursday's Pre-Market Session ↗

August 17, 2023

Via Benzinga

Why Modular Medical Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket ↗

August 17, 2023

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares surged 34.3% to $1.37 in pre-market trading after the company announced a partnership with Phillips-Medisize to expand insulin delivery...

Via Benzinga

12 Information Technology Stocks Moving In Monday's After-Market Session ↗

August 14, 2023

Via Benzinga

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

12 Information Technology Stocks Moving In Thursday's Pre-Market Session ↗

August 03, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 03, 2023

We're starting off the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday morning!

Via InvestorPlace

XTI Aircraft’s Proposed Merger with Inpixon to Elevate VTOL Industry

August 02, 2023

Via AB Newswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Talaris Therapeutics, Inc. (Nasdaq - TALS), Inpixon® (Nasdaq - INPX)

August 01, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

July 31, 2023

Gainers

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)

July 28, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

12 Information Technology Stocks Moving In Friday's Intraday Session ↗

July 28, 2023

Via Benzinga

Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 28, 2023

Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.

Via Benzinga

INPIXON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Inpixon - INPX

July 28, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

12 Information Technology Stocks Moving In Friday's Pre-Market Session ↗

July 28, 2023

Via Benzinga

Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

July 28, 2023

Gainers Unique Fabricating, Inc. (NASDAQ: UFAB) shares surged 62.6% to $0.3512 in pre-market trading after gaining 12% on Thursday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 28, 2023

We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!

Via InvestorPlace

12 Information Technology Stocks Moving In Thursday's After-Market Session ↗

July 27, 2023

Via Benzinga

12 Information Technology Stocks Moving In Thursday's Intraday Session ↗

July 27, 2023

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.